Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone in the body to help regulate blood sugar and appetite
So, how do clinicians Read More Initiating GLP-1 Therapy Through Telehealth: What Clinicians Need to Monitor May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,637 views As virtual care becomes more common, many clinicians now initiate GLP-1 receptor agonist therapy remotely
10.1002/hep.1840090104 10 BatmunkhB.ChoijookhuuN.SrisowannaN.ByambatsogtU.Synn OoP.Noor AliM.et al (2017)
Code availability Code for preprocessing SomaScan proteomics data, performing statistical analyses and generating figures is available via Zenodo at (ref
Consult your healthcare provider to determine which medication best fits your treatment plan, health conditions, and overall health goals
Monitoring and follow-up: Regular follow-up during the first 3-6 months of therapy allows for symptom assessment, dose optimization, and early identification of complications